Clinical Trials Logo

Gender Dysphoria clinical trials

View clinical trials related to Gender Dysphoria.

Filter by:

NCT ID: NCT05726903 Recruiting - Clinical trials for Gender Dysphoria, Adolescent

Counseling Among Gender Diverse Adolescents Who Use Depot Medroxyprogesterone

Start date: December 6, 2022
Phase: Phase 4
Study type: Interventional

Recommendations regarding contraceptive counseling and reproductive health differ amongst transgender and gender diverse (TGD) youth compared to cis-gender youth. Limited existing literature demonstrates the need for contraceptive counseling that moves beyond cis- and heteronormative assumptions that start with pregnancy prevention and address concerns at the intersection of gender identity. The Investigator's qualitative study will focus on creating best practices regarding equitable contraceptive counseling for TGD youth. The Investigator will recruit transgender youth who are assigned female at birth, and currently or interested in using depo medroxyprogesterone (DMPA). Through focus groups and semi-structured interviews, the investigator hopes to guide providers in creating best practices and more equitable contraceptive counseling for TGD youth and measure satisfaction of DMPA in TGD youth.

NCT ID: NCT05649605 Recruiting - Gender Dysphoria Clinical Trials

Early Mental Response - The EMRE Study

EMRE
Start date: March 7, 2023
Phase: N/A
Study type: Interventional

Primary question: Does transgender men's experience of gender incongruence improve within 6 weeks of hormonal treatment compared to placebo? Long before any bodily changes occur. Secondary question: Does transgender men´s experience of self-esteem, quality of life, sexual desire, aggression, depression/anxiety, impulsiveness, and emotional reactivity improve during 6 weeks of cross-sex hormone therapy compared to placebo? Gender dysphoria is a condition characterized by a perceived incongruence between the body and identity. For several decades this condition has been treated with cross-sex hormone therapy and surgery, among others, in order to change the body to be more congruent with the perceived gender identity. Patient satisfaction with this treatment is very high where an overwhelming majority of patients live the rest of their lives according to their perceived gender. A clinical observation, however, is that most patients experience that the congruence between the perceived gender and the assigned one improves very quickly on hormonal treatment. Long before any changes to the body have taken place. This may be partly due to relief from having finally started treatment (i.e. a psychological/social explanation) but an alternative (and much more likely) explanation is that the hormonal treatment directly affects the brain. Since the cause of gender dysphoria is unknown today, this study is therefore a step in trying to clarify the mechanism. In addition, it is of value to be able to demonstrate the benefits of hormonal treatment in these patients. Finally, there is a basic research motive for this study. The effect of sex hormones on the brain is very well known from a clinical perspective but all the more unknown from a research perspective. This study will contribute knowledge in this area.

NCT ID: NCT05489159 Recruiting - Insulin Resistance Clinical Trials

Sleep and IR in Transgender Adolescents

ATP
Start date: October 12, 2022
Phase:
Study type: Observational

Disordered sleep is a health issue with significant impacts on physical and psychological well-being that has increased in prevalence, but its impact on transgender adolescents has not been fully quantified. While there is found to be an impact of sex steroids on sleep, and sex-dependent differences in the impact of sleep duration and quality on insulin resistance (IR), there is limited available information regarding the impact of Gender Affirming Hormone Therapy (GAHT) for transgender individuals on sleep and IR. Our study aims to quantify the impacts of GAHT on sleep and IR in the pediatric transgender population as well as determine the degree of correlation of sleep to IR in this population.

NCT ID: NCT05318755 Recruiting - Transgender Clinical Trials

China Gender-affirming Hormone Therapy Study

CGAHT
Start date: April 16, 2022
Phase:
Study type: Observational

Data about transgender medical care, especially the gender-affirming hormone therapy (GAHT) is extremely insufficient in China. Few evidence exists in the physical and psychological effects of the hormonal treatment in Chinese transgender population. CGAHT is designed to describe the social and mental condition of transgender people who are seeking for formal GAHT, and to investigate the physical and psychological effects of GAHT on this population in China.

NCT ID: NCT05204732 Recruiting - Gender Dysphoria Clinical Trials

Acoustic and Perceptual Effects of Intonation Training in Gender Diverse People

Start date: March 30, 2022
Phase: N/A
Study type: Interventional

The aim of this project is to investigate the short- and the longer-term effect of intonation training on vocal characteristics, listener perceptions and patient related outcome measures (PROMS) in gender diverse people using a randomized sham-controlled trial.

NCT ID: NCT05166083 Recruiting - Gender Dysphoria Clinical Trials

Investigation of the Perceptual and Acoustic Voice in Trans Man

Start date: March 11, 2022
Phase:
Study type: Observational [Patient Registry]

The aim of the study is to follow acoustic and perceptual voice changes in trans men during hormone therapy and to examine the relationship between psychosocial and vocal characteristics and testosterone measured in routine follow-up in accordance with international follow-up guidelines.

NCT ID: NCT05097820 Recruiting - Testicular Cancer Clinical Trials

Prospective Observational Study on SEBBIN Silicone Gel-filled Testicular Implants

Start date: February 5, 2021
Phase:
Study type: Observational [Patient Registry]

To analyze the short and long term postoperative clinical outcome and patient satisfaction of silicone gel-filled testicular implants.

NCT ID: NCT04993469 Recruiting - Gender Dysphoria Clinical Trials

Patient Reported Outcome on Genital Sensitivity and Sexual Function After Genital Gender Affirming Surgery

PROGAS
Start date: May 27, 2021
Phase: N/A
Study type: Interventional

For genital gender affirming surgery, it remains unclear to what extent genital sensitivity might be expected and what the impact of this might be on sexual functioning.

NCT ID: NCT04979338 Recruiting - Gender Dysphoria Clinical Trials

Development of Effective, Opioid Sparing Techniques for Peri-operative Pain Management of Transgender Patients Undergoing Gender Affirming Surgeries

Start date: November 11, 2021
Phase: Phase 3
Study type: Interventional

This study will compare the current standard-of-care pain treatment regimen options that are available to patients who undergo gender-affirming surgery. The purpose of this research is to determine if any of these options are more (versus less) effective than the others to manage surgery related pain, after surgery.

NCT ID: NCT04935164 Recruiting - Clinical trials for Gender Dysphoria, Adult

Comparative Study of Gender Identity Disorder Versus Control

TRANSIDENT
Start date: March 26, 2021
Phase:
Study type: Observational

Gender dysphoria is manifested by an internal tension between biological sex and gender, that is, by a non-congruence, in the subjects who suffer from it, between their sex of birth and their social gender identity.